G. Dumoulin et al., NO TREND TOWARD A SPONTANEOUS IMPROVEMENT OF HYPERPARATHYROIDISM AND HIGH BONE TURNOVER IN NORMOCALCEMIC LONG-TERM RENAL-TRANSPLANT RECIPIENTS, American journal of kidney diseases, 29(5), 1997, pp. 746-753
Although hyperparathyroidism is a common feature in renal transplant r
ecipients, the long-term course of parathyroid hormone (PTH) secretion
in these patients is not well established, and the actual contributio
n of PTH to posttransplant bone disease remains incompletely understoo
d. Therefore, we studied calcium-regulating hormones and serum osteoca
lcin, as a marker of bone remodeling, in 82 normocalcemic renal transp
lant recipients with good renal function who had received a graft 6 to
73 months previously and in 82 healthy subjects matched for age and s
ex. In all subjects, fasting serum and 24-hour urinary samples were co
llected. The transplant recipients had excessive PTH secretion (serum
PTH, 6.9 +/- 0.5 pmol/L in recipients v 3.0 +/- 0.1 pmol/L in healthy
subjects; P < 0.001) and high bone turnover (osteocalcin, 16.6 +/- 0.8
mu g/L v 8.0 +/- 0.3 mu g/L; P < 0.001). (Values are mean +/- SEM.) I
n addition, transplant recipients had a slightly higher ionized calciu
m than the healthy subjects, providing definite evidence of an inappro
priate PTH secretion in renal transplant recipients. Furthermore, in s
ubgroups of 25 recipients and 25 healthy controls matched for creatini
ne clearance, the results superimposed those obtained in the whole gro
ups, suggesting that excessive PTH secretion and high bone turnover in
renal transplant recipients did not merely reflect the moderately red
uced renal function of some recipients. In the whole group of transpla
nt recipients, PTH correlated positively with osteocalcin (r = 0.40; P
< 0.001), suggesting that PTH contributes at least partly to posttran
splant bone disease. Conversely, there was no correlation between seru
m PTH or osteocalcin and the delay from grafting. Therefore, our resul
ts provide no evidence for a spontaneous improvement of either persist
ent hyperparathyroidism or high bone turnover in normocalcemic long-te
rm renal transplant recipients. (C) 1997 by the National Kidney Founda
tion, Inc.